pipette
ESEspañol

Albumin-bound paclitaxel–induced stromal reprogramming drives resistance to neoadjuvant chemotherapy in patients with pancreatic cancer

Haorui Li, Xi Ma, Xupeng Hou, Xugang Sun, Xiang He, Kejia Liu, Henan Cao, Libo Wang, Yibo Dou, Jie Yu, Bin Wang, Tianxing Zhou, Chuntao Gao, Jun Yu, Yongjie Xie, Yukuan Feng, Tiansuo Zhao, Jihui Hao

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
These findings map chemotherapy-induced CAF plasticity, reveal a TMEM100-AREG axis of resistance, and highlight TMEM100 + CAFs as a promising target to sensitize PDAC to neoadjuvant treatment.

Appeared: Friday, November 13. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aee4086